Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Duloxetine Atorvastatin Intermediates Companies

Information about specific intermediate products used in the synthesis of drugs, such as duloxetine and atorvastatin intermediates, can be proprietary and may not be publicly disclosed by the companies involved. However, I can provide general information about the companies that are commonly involved in the production of pharmaceutical intermediates.

Duloxetine Intermediate and Atorvastatin Intermediates Key CompaniesLatest Duloxetine Intermediate and Atorvastatin Intermediates Companies Update



  • June 2023: CMP Pharma, Inc. declared that Atorvaliq (atorvastatin calcium), which had been officially approved by the FDA, is now commercially available. Developed to address elevated cholesterol levels and various cardiovascular disease and stroke risk factors, the medication is a liquid oral suspension that has received approval for use in patients aged 10 years and older. Atorvaliq is specifically designed for a subset of patients who require atorvastatin but experience dysphagia or challenge ingesting tablets. The provision of Atorvaliq as a liquid formulation by the FDA guarantees convenience, safety, and approval for healthcare providers and suitable patients. A 150mL container of Atorvaliq oral suspension contains 20mg/5mL of atorvastatin calcium. There is no refrigeration requirement for this item, and it has a 24-month shelf life.



  • Sun Pharmaceutical Industries, Inc. (Sun Pharma), a wholly owned subsidiary of Sun Pharmaceutical Industries Limited based in Mumbai, declared today that Drizalma Sprinkleâ„¢ is now covered by the top ten Medicare Part D plans, which encompass 91% of eligible U.S. lives. Drizalma Sprinkleâ„¢ is one of three sprinkle formulation products in Sun Pharma's long-term care (LTC) portfolio. These products are prescribed to the forty percent of American adults who cannot or will not ingest solid medication forms, both inside and outside of LTC facilities. Drizalma Sprinkleâ„¢ is the initial and sole sprinkle formulation of delayed-release duloxetine capsules to receive approval from the U.S. Food and Drug Administration (FDA). It is approved for the treatment of generalized anxiety disorder (GAD) in pediatric patients aged 7-17 and major depressive disorder (MDD), diabetic peripheral neuropathy pain (DPNP), and chronic musculoskeletal pain in adults.


List of Duloxetine Intermediate and Atorvastatin Intermediates Key companies in the market

  • Jiangxi Aifeimu Technology Co., Ltd

  • Zhejiang Jiuzhou Pharmaceutical Co., Ltd,

  • Jigs Chemicals

  • Manus Aktteva

  • Arch Pharmalabs

  • Afine Chemicals Ltd

  • Shodhana Laboratories

  • Fluorochem Ltd

  • Chiral Bio Sciences Ltd

  • Tokyo Chemical Industry Co., Ltd.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.